Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?
COVID-19 vaccine
Italy
SARS-CoV-2 Omicron variant
epidemiology
hospitalization
outbreak
surveillance
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
13 Feb 2022
13 Feb 2022
Historique:
received:
25
01
2022
revised:
09
02
2022
accepted:
10
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
27
2
2022
Statut:
epublish
Résumé
The Omicron variant of concern (VOC), first detected in Italy at the end of November 2021, has since spread rapidly, despite high vaccine coverage in the Italian population, especially in healthcare workers (HCWs). This study describes an outbreak of SARS-CoV-2 Omicron infection in 15 booster-vaccinated HCWs. On 16 December 2021, two HCWs working in the same ward were infected with SARS-CoV-2. The Omicron VOC was suspected due to S gene target failure on molecular testing. Further investigation revealed that 15 (65%) of 23 HCWs attending a social gathering on 13 December were infected with Omicron, as shown by whole-genome sequencing, with a phylogenetic tree suggesting a common source of exposure. Five of these HCWs experienced mild symptoms. A patient with multiple chronic conditions hospitalized in the same ward was also infected by one of the HCWs involved in the outbreak. Despite being booster vaccinated, this patient required ICU treatment. Ten subjects achieved negativity in 10-19 days. The outbreak in booster-vaccinated subjects confirms the high transmissibility and immune evasion of the Omicron VOC. More stringent non-pharmaceutical interventions, administration of booster doses, and genomic surveillance are crucial long-term strategies to mitigate the consequences of the spread of the Omicron VOC.
Identifiants
pubmed: 35214741
pii: vaccines10020283
doi: 10.3390/vaccines10020283
pmc: PMC8880534
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Environ Res Public Health. 2021 Apr 29;18(9):
pubmed: 33947087
Lancet. 2021 Dec 4;398(10316):2093-2100
pubmed: 34756184
N Engl J Med. 2022 Feb 3;386(5):494-496
pubmed: 34965358
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915975
Nature. 2021 Dec;600(7888):197-199
pubmed: 34857948
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915977
Transpl Infect Dis. 2021 Dec 30;:e13782
pubmed: 34969164
Clin Infect Dis. 2022 Feb 03;:
pubmed: 35134167
Clin Microbiol Infect. 2021 Aug;27(8):1174.e1-1174.e4
pubmed: 33984489
JAMA. 2022 Feb 8;327(6):583-584
pubmed: 34967859
EBioMedicine. 2022 Jan;75:103788
pubmed: 34954658
Cell. 2022 Feb 3;185(3):457-466.e4
pubmed: 34995482
Lancet. 2021 Dec 11;398(10317):2126-2128
pubmed: 34871545
Lancet. 2021 Nov 13;398(10313):1825-1835
pubmed: 34717829
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1782-1784
pubmed: 34968376
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Viruses. 2021 May 12;13(5):
pubmed: 34066205